Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 5, 2015, Pages 906-912.e2

  Lanas, Angel ^a,b   Carrera Lasfuentes, Patricia ^b   Arguedas, Yolanda ^a   García, Santiago ^c   Bujanda, Luis ^b,d   Calvet, Xavier ^b,e   Ponce, Julio ^b,f   Perez Aísa, Ángeles ^g   Castro, Manuel ^b,h   Muñoz, Maria ^a   Sostres, Carlos ^a   García Rodríguez, Luis A ⁱ  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^d HOSPITAL DONOSTIA   (Spain)

^e Sabadell Universitary Hospital   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g HOSPITAL COSTA DEL SOL   (Spain)

^h HOSPITAL UNIVERSITARIO DE VALME   (Spain)

ⁱ Department of Pharmacoepidemiology   (Spain)

Author keywords

Colon; Complication; Intestine; Peptic ulcer; Side effect; Small bowel; Stomach

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; THIENOPYRIDINE DERIVATIVE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; LOWER GASTROINTESTINAL BLEEDING; MAJOR CLINICAL STUDY; RISK FACTOR; UPPER GASTROINTESTINAL BLEEDING; CHEMICALLY INDUCED; FEMALE; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RISK ASSESSMENT; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; CASE-CONTROL STUDIES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84927911109     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.11.007     Document Type: Article

References (20)

1. Lanza F.L., Chan F.K., Quigley E.M. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009, 104:728-738.
2. García Rodríguez L.A., Barreales Tolosa L. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology 2007, 132:498-506.
3. Bjarnason I., Hayllar J., Macpherson A.J., et al. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993, 104:1832-1847.
4. Graham D.Y., Opekun A.R., Willingham F.F., et al. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol 2005, 3:55-59.
5. Maiden L., Thjodleifsson B., Seigal A., et al. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clin Gastroenterol Hepatol 2007, 5:1040-1045.
6. Goldstein J.L., Eisen G.M., Lewis B., et al. Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Aliment Pharmacol Ther 2007, 25:1211-1222.
7. Kurahara K., Matsumoto T., Lida M., et al. Clinical and endoscopic features of nonsteroidal anti-inflammatory drug-induced colonic ulcerations. Am J Gastroenterol 2001, 96:473-480.
8. Lanas A., Sekar M.C., Hirschowitz B.I. Objective evidence of aspirin use in both ulcer and non-ulcer upper and lower gastrointestinal bleeding. Gastroenterology 1992, 103:862-869.
9. Yuhara H., Corley D.A., Nakahara F., et al. Aspirin and non-aspirin NSAIDs increase risk of colonic diverticular bleeding: a systematic review and meta-analysis. JGastroenterol 2014, 49:992-1000.
10. Nagata N., Niikura R., Aoki T., et al. Colonic diverticular hemorrhage associated with the use of NSAIDs, low-dose aspirin, antiplatelet drugs, and dual therapy. J Gastroenterol Hepatol 2014, 10:1786-1793.
11. Abraham N.S., Hartman C., Richardson P., et al. Risk of lower and upper gastrointestinal bleeding, transfusions, and hospitalizations with complex antithrombotic therapy in elderly patients. Circulation 2013, 128:1869-1877.
12. Lanas A., García-Rodríguez L.A., Polo-Tomás M., et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol 2009, 104:1633-1641.
13. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009, 373:1849-1860. Antithrombotic Trialists' (ATT) Collaboration.
14. Sostres C., Lanas A. Gastrointestinal effects of aspirin. Nat Rev Gastroenterol Hepatol 2011, 8:385-394.
15. Laine L., Curtis S.P., Cryer B., et al. MEDAL Steering Committee: assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteo-arthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme-a randomised comparison. Lancet 2007, 369:465-473.
16. Laine L., Connors L.G., Reicin A., et al. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Gastroenterology 2003, 124:288-292.
17. Chan F.K., Lanas A., Scheiman J., et al. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet 2010, 376:173-179.
18. Cryer B., Li C., Simon L.S., et al. GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded endpoint (PROBE) trial. Am J Gastroenterol 2013, 108:392-400.
19. Smecuol E., Pinto-Sanchez M.I., Suarez A.A., et al. Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment. Clin Gastroenterol Hepatol 2009, 7:524-529.
20. Wallace J.L., Syer S., Denou E., et al. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology 2011, 141:1314-1322.